
|Articles|April 29, 2022
AJMC® in the Press, April 29, 2022
Author(s)AJMC Staff
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Advertisement
A piece by
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
2
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
3
Making the Genetic Models Match the Ancestry of Patient Populations
4
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
5













































